Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Gönczöl E[au]:

Protection by humoral elements independent of virus neutralization activity against an influenza virus challenge. Sarkadi J et al. New Microbiol. (2017)

Fast vaccine design and development based on correlates of protection (COPs). van Els C et al. Hum Vaccin Immunother. (2014)

Chronic infections and atherosclerosis. Kis Z et al. Acta Microbiol Immunol Hung. (2001)

Search results

Items: 1 to 50 of 109

1.

Protection by humoral elements independent of virus neutralization activity against an influenza virus challenge.

Sarkadi J, Kuti D, Jankovics M, Pallinger E, Fodor K, Kis Z, Gonczol E, Visontai I, Jankovics I.

New Microbiol. 2017 Jul;40(3):180-189. Epub 2017 Jul 4.

2.

Correction for Sarkadi et al., High-Level Cellular and Humoral Immune Responses in Guinea Pigs Immunized Intradermally with a Heat-Inactivated Varicella-Zoster Virus Vaccine.

Sarkadi J, Jankovics M, Fodor K, Kis Z, Takacs M, Visontai I, Jankovics I, Gonczol E.

Clin Vaccine Immunol. 2015 Jul;22(7):844. doi: 10.1128/CVI.00243-15. No abstract available.

3.

High-level cellular and humoral immune responses in Guinea pigs immunized intradermally with a heat-inactivated varicella-zoster virus vaccine.

Sarkadi J, Jankovics M, Fodor K, Kis Z, Takacs M, Visontai I, Jankovics I, Gonczol E.

Clin Vaccine Immunol. 2015 May;22(5):570-7. doi: 10.1128/CVI.00773-14. Epub 2015 Mar 18. Erratum in: Clin Vaccine Immunol. 2015 Jul;22(7):844.

4.

Fast vaccine design and development based on correlates of protection (COPs).

van Els C, Mjaaland S, Næss L, Sarkadi J, Gonczol E, Korsholm KS, Hansen J, de Jonge J, Kersten G, Warner J, Semper A, Kruiswijk C, Oftung F.

Hum Vaccin Immunother. 2014;10(7):1935-48. doi: 10.4161/hv.28639. Review.

5.

Immunization of Chlamydia pneumoniae (Cpn)-infected Apob(tm2Sgy)Ldlr(tm1Her)/J mice with a combined peptide of Cpn significantly reduces atherosclerotic lesion development.

Xia M, Chen D, Endresz V, Faludi I, Szabo A, Gonczol E, Kakkar V, Lu X.

PLoS One. 2013 Dec 13;8(12):e81056. doi: 10.1371/journal.pone.0081056. eCollection 2013. Erratum in: PLoS One. 2014;9(5):e99474.

6.

Protection of Chinese painted quails (Coturnix chinensis) against a highly pathogenic H5N1 avian influenza virus strain after vaccination.

Sarkadi J, Jankovics M, Kis Z, Skare J, Fodor K, Gonczol E, Visontai I, Vajo Z, Jankovics I.

Arch Virol. 2013 Dec;158(12):2577-81. doi: 10.1007/s00705-013-1754-z. Epub 2013 Jun 15.

7.

Impact of multiple antigenic epitopes from ApoB100, hHSP60 and Chlamydophila pneumoniae on atherosclerotic lesion development in Apob(tm2Sgy)Ldlr(tm1Her)J mice.

Lu X, Xia M, Endresz V, Faludi I, Szabo A, Gonczol E, Mundkur L, Chen D, Kakkar V.

Atherosclerosis. 2012 Nov;225(1):56-68. doi: 10.1016/j.atherosclerosis.2012.07.021. Epub 2012 Aug 18.

PMID:
22959702
8.

Immunization with a combination of 2 peptides derived from the C5a receptor significantly reduces early atherosclerotic lesion in Ldlr(tm1Her) Apob(tm2Sgy) J mice.

Lu X, Xia M, Endresz V, Faludi I, Mundkur L, Gonczol E, Chen D, Kakkar VV.

Arterioscler Thromb Vasc Biol. 2012 Oct;32(10):2358-71. doi: 10.1161/ATVBAHA.112.253179. Epub 2012 Jul 26.

PMID:
22837469
9.

Human cytomegalovirus neutralising antibodies and increased risk of coronary artery disease in Indian population.

Mundkur LA, Shivanandan H, Hebbagudi S, Endrész V, Varma M, Rao V, Gonczol E, Kakkar VV.

Heart. 2012 Jul;98(13):982-7. doi: 10.1136/heartjnl-2012-301850.

PMID:
22668865
10.

Immunization with a combination of ApoB and HSP60 epitopes significantly reduces early atherosclerotic lesion in Apobtm2SgyLdlrtm1Her/J mice.

Lu X, Chen D, Endresz V, Xia M, Faludi I, Burian K, Szabo A, Csanadi A, Miczak A, Gonczol E, Kakkar V.

Atherosclerosis. 2010 Oct;212(2):472-80. doi: 10.1016/j.atherosclerosis.2010.06.007. Epub 2010 Jun 11.

PMID:
20609438
11.

Adjuvant modulation of the immune response of mice against the LcrE protein of Chlamydophila pneumoniae.

Faludi I, Burian K, Csanadi A, Miczak A, Lu X, Kakkar VV, Gonczol E, Endresz V.

Int J Med Microbiol. 2009 Nov;299(7):520-8. doi: 10.1016/j.ijmm.2009.04.002. Epub 2009 May 17.

PMID:
19451031
12.

Genotyping of Chlamydia trachomatis from the endocervical specimens of high-risk women in Hungary.

Petrovay F, Balla E, Németh I, Gönczöl E.

J Med Microbiol. 2009 Jun;58(Pt 6):760-4. doi: 10.1099/jmm.0.008607-0.

PMID:
19429752
13.

Inflammatory- and immune responses in relation to bacterial replication in mice following re-infections with Chlamydophila pneumoniae.

Kis Z, Burian K, Treso B, Acs K, Prohaszka Z, Fust G, Gonczol E, Endresz V.

Inflamm Res. 2008 Jun;57(6):287-95. doi: 10.1007/s00011-007-7124-0.

PMID:
18516711
14.

Expression of bacterial genes and induction of INF-gamma in human myeloid dendritic cells during persistent infection with Chlamydophila pneumoniae.

Kis Z, Treso B, Burian K, Endresz V, Pallinger E, Nagy A, Toth A, Takacs M, Falus A, Gonczol E.

FEMS Immunol Med Microbiol. 2008 Apr;52(3):324-34. doi: 10.1111/j.1574-695X.2007.00367.x. Epub 2008 Feb 27.

15.

Chronic infections and histamine, CRP and IL-6 levels after percutaneous transluminal coronary angioplasty.

Petrovay F, Heltai K, Kis Z, Treso B, Gonczol E, Burian K, Endresz V, Valyi-Nagy I.

Inflamm Res. 2007 Sep;56(9):362-7.

PMID:
17878998
16.

Chronic infections and genetic factors in the development of ischemic stroke.

Kis Z, Sas K, Gyulai Z, Treso B, Petrovay F, Kapusinszky B, Csire M, Endresz V, Burian K, Mandi Y, Vecsei L, Gonczol E.

New Microbiol. 2007 Jul;30(3):213-20.

17.

A soluble factor(s) released by MRC-5 cells early and late after human cytomegalovirus infection induces maturation of monocyte-derived dendritic cells.

Kis Z, Pallinger E, Endresz V, Burian K, Falus A, Berencsi G, Gonczol E.

Arch Virol. 2006 Nov;151(11):2277-87. Epub 2006 Jun 16.

PMID:
16773236
18.

Chlamydophila pneumoniae and human cytomegalovirus in atherosclerotic carotid plaques--combined presence and possible interactions.

Virok D, Kis Z, Kari L, Barzo P, Sipka R, Burian K, Nelson DE, Jackel M, Kerenyi T, Bodosi M, Gönczol E, Endresz V.

Acta Microbiol Immunol Hung. 2006 Mar;53(1):35-50.

PMID:
16696549
19.

Human cytomegalovirus latency is associated with the state of differentiation of the host cells: an in vitro model in teratocarcinoma cells.

Dósa R, Burián K, Gönczöl E.

Acta Microbiol Immunol Hung. 2005;52(3-4):397-406. Review.

PMID:
16400879
20.

High rate of early restenosis after carotid eversion endarterectomy in homozygous carriers of the normal mannose-binding lectin genotype.

Rugonfalvi-Kiss S, Dósa E, Madsen HO, Endrész V, Prohászka Z, Laki J, Karádi I, Gönczöl E, Selmeci L, Romics L, Füst G, Entz L, Garred P.

Stroke. 2005 May;36(5):944-8. Epub 2005 Mar 24.

PMID:
15790942
21.

The interactions between human dendritic cells and microbes; possible clinical applications of dendritic cells.

Kis Z, Pallinger E, Endresz V, Burian K, Jelinek I, Gonczol E, Valyi-Nagy I.

Inflamm Res. 2004 Sep;53(9):413-23. Review.

PMID:
15550994
22.

Elevated antibody levels against Chlamydia pneumoniae, human HSP60 and mycobacterial HSP65 are independent risk factors in myocardial infarction and ischaemic heart disease.

Heltai K, Kis Z, Burian K, Endresz V, Veres A, Ludwig E, Gönczöl E, Valyi-Nagy I.

Atherosclerosis. 2004 Apr;173(2):339-46.

PMID:
15064111
23.

Infection of U937 monocytic cells with Chlamydia pneumoniae induces extensive changes in host cell gene expression.

Virok D, Loboda A, Kari L, Nebozhyn M, Chang C, Nichols C, Endresz V, Gonczol E, Berencsi K, Showe MK, Showe LC.

J Infect Dis. 2003 Nov 1;188(9):1310-21. Epub 2003 Oct 13.

PMID:
14593587
24.

Chlamydophila (Chlamydia) pneumoniae induces histidine decarboxylase production in the mouse lung.

Burián K, Hegyesi H, Buzás E, Endrész V, Kis Z, Falus A, Gönczöl E.

Immunol Lett. 2003 Oct 31;89(2-3):229-36.

PMID:
14556983
25.

Association of Chlamydia pneumoniae with coronary artery disease and its progression is dependent on the modifying effect of mannose-binding lectin.

Rugonfalvi-Kiss S, Endrész V, Madsen HO, Burián K, Duba J, Prohászka Z, Karádi I, Romics L, Gönczöl E, Füst G, Garred P.

Circulation. 2002 Aug 27;106(9):1071-6.

PMID:
12196331
26.

Effect of previous or simultaneous immunization with canarypox expressing cytomegalovirus (CMV) glycoprotein B (gB) on response to subunit gB vaccine plus MF59 in healthy CMV-seronegative adults.

Bernstein DI, Schleiss MR, Berencsi K, Gonczol E, Dickey M, Khoury P, Cadoz M, Meric C, Zahradnik J, Duliege AM, Plotkin S.

J Infect Dis. 2002 Mar 1;185(5):686-90. Epub 2002 Feb 6.

PMID:
11865427
27.

Chronic infections and atherosclerosis.

Kis Z, Burián K, Virók D, Kari G, Endrész V, Gönczöl E.

Acta Microbiol Immunol Hung. 2001;48(3-4):497-510. Review.

PMID:
11791347
28.

Development of a cytomegalovirus vaccine: lessons from recent clinical trials.

Gonczol E, Plotkin S.

Expert Opin Biol Ther. 2001 May;1(3):401-12. Review.

PMID:
11727514
29.

Chlamydia pneumoniae exacerbates aortic inflammatory foci caused by murine cytomegalovirus infection in normocholesterolemic mice.

Burian K, Berencsi K, Endresz V, Gyulai Z, Valyi-Nagy T, Valyi-Nagy I, Bakay M, Geng Y, Virok D, Kari L, Hajnal-Papp R, Trinchieri G, Gonczol E.

Clin Diagn Lab Immunol. 2001 Nov;8(6):1263-6.

30.

Chlamydia pneumoniae in atherosclerotic middle cerebral artery.

Virok D, Kis Z, Karai L, Intzedy L, Burian K, Szabo A, Ivanyi B, Gonczol E.

Stroke. 2001 Sep;32(9):1973-6.

PMID:
11546883
31.

Optimization of DNA immunization against human cytomegalovirus.

Endrész V, Burián K, Berencsi K, Gyulai Z, Kari L, Horton H, Virok D, Méric C, Plotkin SA, Gönczöl E.

Vaccine. 2001 Jul 16;19(28-29):3972-80.

PMID:
11427273
32.

A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects.

Berencsi K, Gyulai Z, Gönczöl E, Pincus S, Cox WI, Michelson S, Kari L, Meric C, Cadoz M, Zahradnik J, Starr S, Plotkin S.

J Infect Dis. 2001 Apr 15;183(8):1171-9. Epub 2001 Mar 13.

PMID:
11262198
33.

Independent and joint effects of antibodies to human heat-shock protein 60 and Chlamydia pneumoniae infection in the development of coronary atherosclerosis.

Burian K, Kis Z, Virok D, Endresz V, Prohaszka Z, Duba J, Berencsi K, Boda K, Horvath L, Romics L, Fust G, Gonczol E.

Circulation. 2001 Mar 20;103(11):1503-8.

PMID:
11257076
34.

Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals: reevaluation of prevalence of IE1-specific CTLs.

Gyulai Z, Endresz V, Burian K, Pincus S, Toldy J, Cox WI, Meric C, Plotkin S, Gönczöl E, Berencsi K.

J Infect Dis. 2000 May;181(5):1537-46. Epub 2000 May 15.

PMID:
10823751
35.

Chlamydia pneumoniae inhibits apoptosis in human peripheral blood mononuclear cells through induction of IL-10.

Geng Y, Shane RB, Berencsi K, Gonczol E, Zaki MH, Margolis DJ, Trinchieri G, Rook AH.

J Immunol. 2000 May 15;164(10):5522-9.

36.

Roles of interleukin-12 and gamma interferon in murine Chlamydia pneumoniae infection.

Geng Y, Berencsi K, Gyulai Z, Valyi-Nagy T, Gonczol E, Trinchieri G.

Infect Immun. 2000 Apr;68(4):2245-53.

37.

A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne).

Adler SP, Plotkin SA, Gonczol E, Cadoz M, Meric C, Wang JB, Dellamonica P, Best AM, Zahradnik J, Pincus S, Berencsi K, Cox WI, Gyulai Z.

J Infect Dis. 1999 Sep;180(3):843-6.

PMID:
10438376
38.

Involvement of a p53-dependent pathway in rubella virus-induced apoptosis.

Megyeri K, Berencsi K, Halazonetis TD, Prendergast GC, Gri G, Plotkin SA, Rovera G, Gönczöl E.

Virology. 1999 Jun 20;259(1):74-84.

39.

Induction of human cytomegalovirus (HCMV)-glycoprotein B (gB)-specific neutralizing antibody and phosphoprotein 65 (pp65)-specific cytotoxic T lymphocyte responses by naked DNA immunization.

Endresz V, Kari L, Berencsi K, Kari C, Gyulai Z, Jeney C, Pincus S, Rodeck U, Méric C, Plotkin SA, Gönczöl E.

Vaccine. 1999 Jan;17(1):50-8.

PMID:
10078607
40.

Early atherosclerotic plaques in the aorta following cytomegalovirus infection of mice.

Berencsi K, Endresz V, Klurfeld D, Kari L, Kritchevsky D, Gönczöl E.

Cell Adhes Commun. 1998 Jan;5(1):39-47.

PMID:
9638340
41.

Application of near infrared spectroscopy to the determination of haemoglobin.

Vályi-Nagy I, Kaffka KJ, Jákó JM, Gönczöl E, Domján G.

Clin Chim Acta. 1997 Aug 8;264(1):117-25.

PMID:
9267708
42.

Human colorectal cancer (CRC) antigen CO17-1A/GA733 encoded by adenovirus inhibits growth of established CRC cells in mice.

Li W, Berencsi K, Basak S, Somasundaram R, Ricciardi RP, Gönczöl E, Zaloudik J, Linnenbach A, Maruyama H, Miniou P, Herlyn D.

J Immunol. 1997 Jul 15;159(2):763-9.

PMID:
9218593
43.
44.

Preclinical evaluation of an ALVAC (canarypox)--human cytomegalovirus glycoprotein B vaccine candidate.

Gönczöl E, Berensci K, Pincus S, Endresz V, Méric C, Paoletti E, Plotkin SA.

Vaccine. 1995 Aug;13(12):1080-5.

PMID:
7491815
45.

Cloned antigens and antiidiotypes.

Herlyn D, Somasundaram R, Zaloudik J, Li W, Jacob L, Harris D, Kieny MP, Ricciardi R, Gonczol E, Sears H, et al.

Hybridoma. 1995 Apr;14(2):159-66.

PMID:
7590774
46.
47.

The safety and use of canarypox vectored vaccines.

Plotkin SA, Cadoz M, Meignier B, Méric C, Leroy O, Excler JL, Tartaglia J, Paoletti E, Gonczol E, Chappuis G.

Dev Biol Stand. 1995;84:165-70.

PMID:
7796950
48.

Early region 3-replacement adenovirus recombinants are less pathogenic in cotton rats and mice than early region 3-deleted viruses.

Berencsi K, Uri A, Valyi-Nagy T, Valyi-Nagy I, Meignier B, Peretz FV, Rando RF, Plotkin SA, Gönczöl E.

Lab Invest. 1994 Sep;71(3):350-8.

PMID:
7933985
49.

Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis.

Yang Y, Nunes FA, Berencsi K, Gönczöl E, Engelhardt JF, Wilson JM.

Nat Genet. 1994 Jul;7(3):362-9.

PMID:
7522742
50.

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.

Yang Y, Nunes FA, Berencsi K, Furth EE, Gönczöl E, Wilson JM.

Proc Natl Acad Sci U S A. 1994 May 10;91(10):4407-11.

Supplemental Content

Loading ...
Support Center